malignant melanoma

Open Access
Acyclic Retinoid Overcomes Vemurafenib Resistance in Melanoma Cells via Dual Inhibition of MAPK and PI3K/AKT/mTOR Pathways
YUI SUZUKI, SOICHIRO USUKI, MITSUAKI NISHIZAWA, NORIYOSHI TANAKA, YOSHITOMO SUHARA and ICHIRO YAJIMA

Anticancer Research June 2025, 45 (6) 2265-2278; DOI: https://doi.org/10.21873/anticanres.17601
You have access
Antitumor Activity of Ex Vivo Expanded Tumor Antigen Priming Cytotoxic T Cells Against Malignant Melanoma
HOE-SUN YOON, YOUNG GYU PARK, DAE YOEN CHO, JONG-SEOK KIM and JONG GWON CHOI

Anticancer Research June 2025, 45 (6) 2339-2350; DOI: https://doi.org/10.21873/anticanres.17607
Open Access
Malignant Melanoma: Vitamin D Status as a Risk and Prognostic Factor – Meta-analyses and Systematic Review
SINAN HADDAD, JULIUS JOHANNES WEISE, STEFAN WAGENPFEIL, THOMAS VOGT and JOERG REICHRATH

Anticancer Research January 2025, 45 (1) 27-37; DOI: https://doi.org/10.21873/anticanres.17390
Open Access
Resveratrol Can Differentiate Human Melanoma Stem-like Cells from Spheroids Treated With All-trans Retinoic Acid
MINA KANAI, AKIHO SHINAGAWA, MASAKO OTA, NANTIGA VIRGONA and TOMOHIRO YANO

Anticancer Research December 2024, 44 (12) 5283-5292; DOI: https://doi.org/10.21873/anticanres.17356
You have access
Gene Profiling of Cannabis-sativa-mediated Apoptosis in Human Melanoma Cells
KANITA POOMMARAPAN, PAISAL RUMMANEETHORN, ATTASIT SRISUBAT, NUNTAKAN SUWANPIDOKKUL, PETCHPAILIN LEENUTAPHONG, THAMTHIWAT NARARATWANCHAI, SIRADA SRIHIRUN, WANTHANEE PHETCHENGKAO, KANKANIT SURIYACHAN and SALUNYA TANCHAROEN

Anticancer Research March 2023, 43 (3) 1221-1237; DOI: https://doi.org/10.21873/anticanres.16269
Open Access
CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells
NAHO FUJII, MASAKAZU YASHIRO, TAKAHARU HATANO, HEISHIRO FUJIKAWA and HISASHI MOTOMURA

Anticancer Research January 2023, 43 (1) 25-33; DOI: https://doi.org/10.21873/anticanres.16130
You have access
Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
CARSTEN NIEDER, SIV GYDA AANES and ELLINOR C. HAUKLAND

Anticancer Research June 2022, 42 (6) 3061-3066; DOI: https://doi.org/10.21873/anticanres.15793
You have access
Nivolumab for the Treatment of Advanced Pediatric Malignancies
AGATA MARJAŃSKA, MONIKA DROGOSIEWICZ, BOŻENNA DEMBOWSKA-BAGIŃSKA, KATARZYNA PAWIŃSKA-WĄSIKOWSKA, WALENTYNA BALWIERZ, KATARZYNA BOBEFF, WOJCIECH MŁYNARSKI, AGNIESZKA MIZIA-MALARZ, ANNA RACIBORSKA, MARIUSZ WYSOCKI and JAN STYCZYŃSKI

Anticancer Research December 2020, 40 (12) 7095-7100; DOI: https://doi.org/10.21873/anticanres.14738
You have access
Melanoma Risk Estimation Based on Objective Measures as a Complement to Self-Assessment
ADAM CARLSSON and MAGNUS FALK

Anticancer Research June 2020, 40 (6) 3325-3331; DOI: https://doi.org/10.21873/anticanres.14315
You have access
National Comprehensive Analysis of Characteristics of Acral Lentiginous Melanoma
MARIA T. HUAYLLANI, DAVID J. RESTREPO, DANIEL BOCZAR, FRANCISCO R. AVILA, SANJAY P. BAGARIA, AARON C. SPAULDING, BRIAN D. RINKER and ANTONIO J. FORTE

Anticancer Research June 2020, 40 (6) 3411-3415; DOI: https://doi.org/10.21873/anticanres.14325

Main menu

User menu

Search

malignant melanoma

Pages